BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

(RTTNews) - Sonoma Pharmaceuticals, Inc. (SNOA) said it has launched Microdox, an urinary tract infection catheter and bladder rinse in New Zealand, Australia and South Africa. Microdox is a ...

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has launched Microdox, an urinary tract infection catheter and bladder rinse in New Zealand, Australia, and South Africa. Microdox is a super-oxidized ...

Dauramanzi said the manufacturers of Microdox, Microlabs Ltd of India and its present distributor, Sky Pharmaceuticals, had not released the batch in question to pharmaceutical outlets. The drug was ...

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Microdox is a super-oxidized solution based on Sonoma's patented Microcyn technology intended to treat and prevent infections in the urinary tract and bladder. Microdox is licensed by the Therapeutic ...